Device for reading out a test kit for detecting biomarkers
DE102019006582A1
New test kit containing Tumor-M2-PK-specific antibodies and a sample preparation device
CN111044723A
Novel test kit containing trypsin-1-specific antibodies and sample preparation device
DE102018000815A1
Method for the detection of biomarkers in the stool for the detection of diseases of the intestinal tract
DE102016015060A1
Method for the detection of tumor markers in the stool for the detection of gastrointestinal tumors
WO2016015701A1
Bioanalysis device, the production thereof and method for detecting bioanalytes by means of the device
DE102012013888A1
Test kit (combi rapid test) for the synchronous detection of biomarkers in stool for the detection of pathological changes in the gastrointestinal tract, especially in the intestine
DE102010025545A1
Method for the detection of L-PK tumor markers in body fluids, in particular in the stool for the detection of liver diseases
DE102009024296A1
New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis
DE102009019852A1
New polymer compound comprising amine structural elements, useful as synthetic resins, coatings, foams, liquid crystals, adhesives, paints, varnishes, composite materials, in cosmetics, and in polymer electronics
WO2009115084A2
Pyrrolopyrimidine derivatives, and use thereof
WO2009036753A2
Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy
WO2009030224A2
Novel quinazoline compounds and the use thereof for treating cancerous diseases
WO2009018807A1
Oxazolidinones as factor xa inhibitors, methods for the production thereof, and use thereof in therapy
WO2009018811A1
Novel pharmaceuticals, method for the production thereof, and use thereof in medical therapy
WO2008154905A2
Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid
DE102008021699A1
New pyrrolopyrimidine compounds are epidermal growth factor receptor tyrosine kinase inhibitors useful for preventing or treating proliferative or inflammatory disease, where the disease is e.g. cancer, asthma, allergy and psoriasis
DE102008012435A1
New quinazoline compounds are tyrosin-kinase inhibitors e.g. to treat cancer, hematologic or solid tumors, non-Hodgkin tumors or T-cell lymphoma; and for the modulation of the cell cycle, cell differentiation, apoptosis or angiogenesis
US2008153119A1
Detecting the presence of pyruvate kinase isoenzyme in feces
DE102007037373A1
New oxazolidinone derivatives are factor Xa inhibitors useful to treat e.g. acute coronary syndrome, myocardial infarction, angina pectoris, reocclusion, restenosis, stroke, artrial fibrillation, arrhythmia and blood clotting disorder
